Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdMSCs for Osteoarthritis of Knees, Hips, and Shoulders
NCT04448106Phase 2Not yet recruiting
- Sponsor
- Celltex Therapeutics
- Start
- Sep 2023
- Primary completion
- Aug 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Celltex AdMSCs in osteoarthritis (OA), sponsored by Celltex Therapeutics. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
Celltex AdMSCs
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04448106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04448106.